{
  "id": 20306812,
  "title": "Q&A: Can the body's natural signals help wounds heal better with diabetes?",
  "url": "https://urgent.news/2026/11/16/q-a-can-the-bodys-natural-signals-help-wounds-heal-better-with",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-16T17:50:01.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-qa-body-natural-wounds-diabetes.html"
  },
  "original_language": "en",
  "account": "Type 1 diabetes, an autoimmune condition characterized by insufficient insulin production, hampers wound healing. Researchers are investigating ways to enhance the body's natural healing processes. At the American Physiological Society's 2026 Comparative Physiology conference, Pedro Geralde, a professor at the Université de Sherbrooke in Canada, discussed his team's findings. They examined why wounds heal more slowly in individuals with type 1 diabetes and whether two naturally occurring molecules, apelin and ELABELA, could enhance healing. Not all people with type 1 diabetes encounter wound-healing issues, but they generally face a higher risk compared to those without diabetes. Elevated blood sugar levels can affect blood vessels, reduce blood flow, impair immune cell function, and prolong inflammation, all of which can hinder tissue repair and infection-fighting capabilities. Unaddressed, chronic wounds pose a greater risk of infection, potentially leading to severe tissue damage and, in extreme cases, necessitating amputation. Apelin and ELABELA are naturally produced peptide signaling molecules primarily found in vascularized tissue. They do not constitute standard over-the-counter first-aid products or typical prescription wound-care medications. When bound to the apelin receptor, they regulate various biological processes such as blood vessel growth, cardiovascular function, and tissue repair. In their study, apelin and ELABELA were applied directly to wounds in a laboratory setting to evaluate their impact on healing. The results indicated that diabetic mice healed at a slower rate than non-diabetic mice; however, treatment with apelin or ELABELA improved healing. The study also revealed that a specific receptor for these molecules plays a crucial role in immune cells called macrophages, which coordinate inflammation and tissue repair during healing. At present, the findings are preclinical, and their effects on humans have yet to be tested. While more research is required before this approach can be utilized in patients, the study contributes to our understanding of why diabetic wounds heal poorly and suggests potential new treatments to mitigate complications such as chronic wounds and amputations.",
  "summary": "Type 1 diabetes, an autoimmune condition in which the pancreas doesn't produce enough insulin, can make it harder for wounds to heal. Researchers are exploring why and how the body's natural healing processes could be improved. Pedro Geralde, PD, a professor at the Université de Sherbrooke in Canada, shared his team's work at the American Physiological Society's 2026 Comparative Physiology…",
  "key_points": [
    "Type 1 diabetes hampers wound healing due to insufficient insulin production.",
    "Apelin and ELABELA molecules can enhance healing in diabetic wounds.",
    "Study shows diabetic mice healed slower, but treatment improved healing rate."
  ],
  "editors_take": "Targeting naturally occurring signaling molecules offers a potential pathway to bypass the biological impairments caused by high blood sugar and reduce the risk of amputations in diabetic patients.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}